Rice Hall James & Associates’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-47,919
Closed -$803K 259
2024
Q3
$803K Sell
47,919
-27,500
-36% -$660K 0.04% 209
2024
Q2
$2.16M Sell
75,419
-306
-0.4% -$9.21K 0.13% 157
2024
Q1
$2.89M Sell
75,725
-8,400
-10% -$318K 0.16% 136
2023
Q4
$3.13M Buy
84,125
+17,225
+26% +$578K 0.18% 121
2023
Q3
$2.28M Buy
66,900
+14,417
+27% +$544K 0.14% 158
2023
Q2
$2.06M Sell
52,483
-198
-0.4% -$7.15K 0.12% 176
2023
Q1
$1.69M Buy
52,681
+17,562
+50% +$580K 0.1% 204
2022
Q4
$1.09M Buy
+35,119
New +$1.27M 0.06% 228

Other funds holding PGNY

Rice Hall James & Associates's PGNY Position: Q4 2024 in Review

Rice Hall James & Associates sold out of Progyny (PGNY) in Q4 2024, closing a stake of 47,919 shares — an estimated $803K sold.

Rice Hall James & Associates first reported a position in PGNY in Q4 2022 and held it in 8 quarters. The position peaked at $3.13M in Q4 2023. 264 funds tracked by Wall St. Rank hold PGNY as of Q4 2024.

  • Rice Hall James & Associates reported no remaining Progyny position as of Q4 2024 after selling out during the quarter.
  • Rice Hall James & Associates sold 47,919 Progyny shares in Q4 2024, an estimated $803K.
  • Rice Hall James & Associates first reported a position in Progyny in Q4 2022 and held it in 8 quarters.
  • Rice Hall James & Associates's Progyny position peaked at $3.13M in Q4 2023.
  • 264 funds tracked by Wall St. Rank held Progyny as of Q4 2024.

Based on Rice Hall James & Associates's 13F filing for Q4 2024, filed 31 Jan 2025.